- Home
- CMPS vs DSP Comparison
CMPS vs DSP Comparison
Compare CMPS & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- DSP
- Stock Information
- Founded
- CMPS 2020
- DSP 1999
- Country
- CMPS United Kingdom
- DSP United States
- Employees
- CMPS N/A
- DSP N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- DSP EDP Services
- Sector
- CMPS Health Care
- DSP Technology
- Exchange
- CMPS Nasdaq
- DSP Nasdaq
- Market Cap
- CMPS 246.5M
- DSP 291.3M
- IPO Year
- CMPS 2020
- DSP 2021
- Fundamental
- Price
- CMPS $3.91
- DSP $14.92
- Analyst Decision
- CMPS Strong Buy
- DSP Strong Buy
- Analyst Count
- CMPS 6
- DSP 8
- Target Price
- CMPS $20.20
- DSP $21.75
- AVG Volume (30 Days)
- CMPS 862.1K
- DSP 256.9K
- Earning Date
- CMPS 05-08-2025
- DSP 05-06-2025
- Dividend Yield
- CMPS N/A
- DSP N/A
- EPS Growth
- CMPS N/A
- DSP N/A
- EPS
- CMPS N/A
- DSP 0.13
- Revenue
- CMPS N/A
- DSP $306,484,000.00
- Revenue This Year
- CMPS N/A
- DSP $19.25
- Revenue Next Year
- CMPS N/A
- DSP $16.72
- P/E Ratio
- CMPS N/A
- DSP $109.68
- Revenue Growth
- CMPS N/A
- DSP 30.64
- 52 Week Low
- CMPS $2.49
- DSP $8.62
- 52 Week High
- CMPS $9.63
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- CMPS 58.19
- DSP 56.77
- Support Level
- CMPS $3.62
- DSP $12.58
- Resistance Level
- CMPS $4.00
- DSP $15.31
- Average True Range (ATR)
- CMPS 0.28
- DSP 0.83
- MACD
- CMPS -0.00
- DSP 0.14
- Stochastic Oscillator
- CMPS 48.23
- DSP 85.77
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. Through the technology, a marketer can easily buy ads on desktop, mobile, connected TV, linear TV, streaming audio and digital billboards.